FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/30/2025
Back to search
Official data from USPTO
HUMMINGBIRD BIOSCIENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
12/01/2025
Classification
Registered
Trademark type
Combined
Nice classes
5, 42
Filing date
05/24/2022
Registration date
04/22/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/22/2025
Last transaction
12/01/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
24
Owner location
SG
Examiner
STEINPFAD,SARAH E
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a stylized design of a hummingbird in pink. To the right of the design appears the wording "HUMMINGBIRD" in blue and "BIOSCIENCE" in pink. The color white in the mark represents background and is not claimed as a feature of the mark.
Holders and representatives
Holders
Hummingbird Bioscience Pte. Ltd.
Representatives
Maren C. Perry King & Spalding LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the preventiondiagnosistreatment of oncological and immune system diseases for scientificclinicalmedicinaltherapeuticdiagnostic purposes; pharmaceutical and biological preparations for use in the treatment of biological disorders for oncological and immune system diseases; pharmaceutical preparations for therapeutic interventionstherapeutic agents to treat oncological and immune systems diseases ; biological preparations for the treatment of biological disorders for oncological and immune system diseases; anti-cancer drugs; biological preparations for the treatment of cancer; immunological antibodies for medical use; monoclonal antibodies for medical usemonoclonal antibodies for therapeutic purposes; preparations containing antibodies for use in medicine; reagents for use in the development of monoclonal antibodies for medical purposes
Class 42
Medical researchmedical research services; scientific research for medical purposes in the area of cancerous drugs; biomedical research services; drug discovery services; scientific and technological research and design in the field of medical biotechnology; scientific and technological industrial analysis and research services; scientific research in the development of new therapies to treat biological disorders; scientific research for the medical purposes in the area of cancerous diseases; research and development services in the field of antibodies
Publications
History of USPTO decisions and trademark events.
46 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/06/2025
FIMP
FINAL DISPOSITION PROCESSED
11/06/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/22/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/22/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
04/22/2025
PUBO
PUBLISHED FOR OPPOSITION
03/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/04/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/26/2025
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/10/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/07/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/16/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/16/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/16/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/18/2024
GNRT
NON-FINAL ACTION E-MAILED
07/18/2024
CNRT
NON-FINAL ACTION WRITTEN
07/18/2024
ALIE
ASSIGNED TO LIE
06/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/11/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/15/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/25/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/22/2023
GNSL
LETTER OF SUSPENSION E-MAILED
12/22/2023
CNSL
SUSPENSION LETTER WRITTEN
12/22/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/06/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/06/2023
DOCK
ASSIGNED TO EXAMINER
11/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/03/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/03/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/09/2023
RFNT
REFUSAL PROCESSED BY IB
05/23/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/04/2023
RFRR
REFUSAL PROCESSED BY MPU
05/04/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/26/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/26/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/26/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/26/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/26/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/17/2023
CNRT
NON-FINAL ACTION WRITTEN
03/16/2023
DOCK
ASSIGNED TO EXAMINER
03/13/2023
MAFR
APPLICATION FILING RECEIPT MAILED
07/12/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/06/2022
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
07/01/2022
Continuous trademark protection
Get notified about every new filing that threatens HUMMINGBIRD BIOSCIENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.